Markets Business Research Reports Premium Economy & Finance Law & Policy

Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection

NDTV Profit
#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive

RECOMMENDED FOR YOU

Novartis Raises Sales Guidance Citing Cancer, Inflammatory Drugs
timelogo Nov 21, 2024
Supreme Court Refuses To Revoke Injunction Against Sale Of Zydus Lifesciences' Breast Cancer Drug
timelogo Nov 18, 2024
Apollo Hospitals Q2 Results Review - Hospital Business, Apollo 24/7 Drive Earnings: Motilal Oswal
timelogo Nov 08, 2024
Aurobindo Pharma Share Price Declines After US FDA Issues 10 Observations For Telangana Facility
timelogo Sep 30, 2024